Business
BioSpectrum Asia
Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a Memorandum of Understanding (MoU) for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy
Japanese Ministry of Health, Labour and Welfare has approved the use of Takeda's HYQVIA [Immune Globulin Infusion 10 percent (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID).
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
UAE nears completion of National Health Survey
The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has announced a significant milestone in its national surveys project, with 95 percent completion rate for the National Health Survey and 78 percent for the National Nutrition Survey, marking a significant step toward building a robust health database.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Julia Wang steps in as Executive Vice President and CFO at Labcorp
Labcorp, a global leader of innovative and comprehensive laboratory services, has announced that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg has retired from the company and Julia Wang has joined this position.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt
Neuberg Diagnostics has secured Rs 940 crore from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool
RNT Health Insights, an Indian health-tech startup specialising in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation (BDD) for its Oesophageal Cancer detection tool.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Middle East: A rising powerhouse in Medtech and Diagnostics.
The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments.
5 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing
Shanghai-based Alebund Pharmaceuticals, an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, has announced the closing of RMB 550 million in Series C financing.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes
The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia
China-based Bio-Thera Solutions Inc.,
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Merck strikes partnership worth $1.9 B with Chinese biotech Hansoh
Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
US FDA issues draft guidance for developers of AI-enabled medical devices
The US Food and Drug Administration (FDA) has issued draft guidance that includes recommendations to support development and marketing of safe and effective artificial intelligence (AI)enabled devices throughout the device's Total Product Life Cycle.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
PAHO launches interactive dashboard to monitor avian influenza in the Americas
The Pan American Health Organization (PAHO) has launched an interactive dashboard to monitor avian influenza A(H5N1) cases in the Americas.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
"China and Asia are already the global leaders of Antibody-drug conjugates"
Chime Biologics, based in Asia, has positioned itself as a global leader in the Contract Development and Manufacturing Organisation (CDMO) sector.
4 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Innovent Biologics enters into billion-dollar oncology deal with Roche
China-based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, has announced a collaboration and exclusive license agreement with Swiss pharma firm Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
"There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis"
Asia-Pacific region houses some of Galderma's fastest growing markets, where sales have fueled a strong performance.
5 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
AbbVie Biopharma strengthens digital strategies for clinical trials in Taiwan
National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a cooperation agreement, with the agreement jointly signed by President Ming-Shiang Wu of NTUH and General Manager Richard Sun of AbbVie.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Lonza expands capsule manufacturing capacity in India and China
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced capacity expansions at its sites in Rewari (India) and Suzhou (China).
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Primo Biotech partners with SHINE Technologies to advance precision cancer care in APAC
Taiwan-based startup Primo Biotechnology has announced a strategic partnership with US-based SHINE Technologies, LLC, a global leader in nuclear medicine production.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
Singapore launches Global Heat Health Information Network Southeast Asia Hub
The Heat Resilience & Performance Centre (HRPC) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has been officially designated as the Global Heat Health Information Network (GHHIN) Southeast Asia (SEA) Hub, a recognition that underscores its leading role in advancing heat resilience.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
China approves GSK's Nucala for treatment of adults with chronic rhinosinusitis
China National Medical Products Administration (NMPA) has approved GSK's Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSWNP) for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.
1 min |
BioSpectrum Asia Feb 2025
BioSpectrum Asia
"We are dedicated to helping people of all ages see brilliantly"
The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.
5 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.
6 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Building the Future of Medicine
PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical
4 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Emerging Leader in Cell & Gene Therapy
STARTUP OF THE YEAR 2024 - ImmunoACT
3 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Improving Access for Respiratory Healthcare
STARTUP OF THE YEAR 2024 - Aevice Health
4 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Making an Impact with a 'CliKX'
Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ
4 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Eyeing 20-20 Vision of Excellence
Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research
4 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Refining the Use of Radiation
Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals
3 min |
BioSpectrum Asia Jan 2025
BioSpectrum Asia
Honouring Innovators in Asia's Thriving Life Sciences Sector
Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.
2 min |